Kewaunee Scientific Corporation Logo

Kewaunee Scientific Corporation

KEQU

(2.8)
Stock Price

53,87 USD

13.99% ROA

35.01% ROE

5.03x PER

Market Cap.

93.592.288,00 USD

19.82% DER

0% Yield

9.39% NPM

Kewaunee Scientific Corporation Stock Analysis

Kewaunee Scientific Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Kewaunee Scientific Corporation Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (35%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Assets Growth

Over the past five years, this company's revenue has consistently increased, demonstrating a robust financial performance that makes it an appealing opportunity.

3 ROE

ROE in an average range (12.18%) suggests satisfactory profitability and decent utilization of shareholders' equity.

4 ROA

The stock's ROA (3.58%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 PBV

The stock's PBV ratio (1.34x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

6 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

7 Net Profit Growth

The net profit of this company has shown steady growth over the past three years, highlighting its positive financial trajectory and making it an appealing choice for potential investors.

8 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

9 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (2.142), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

10 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

11 Dividend

Investors should be cautious as the company hasn't distributed dividends in the last three years, possibly indicating financial challenges.

Kewaunee Scientific Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Kewaunee Scientific Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Kewaunee Scientific Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Kewaunee Scientific Corporation Revenue
Year Revenue Growth
1986 58.700.000
1987 59.500.000 1.34%
1988 68.600.000 13.27%
1989 68.900.000 0.44%
1990 74.000.000 6.89%
1991 71.100.000 -4.08%
1992 74.900.000 5.07%
1993 67.000.000 -11.79%
1994 66.100.000 -1.36%
1995 62.500.000 -5.76%
1996 57.600.000 -8.51%
1997 62.000.000 7.1%
1998 73.000.000 15.07%
1999 77.500.000 5.81%
2000 74.798.000 -3.61%
2001 77.059.000 2.93%
2002 84.849.000 9.18%
2003 71.163.000 -19.23%
2004 94.700.000 24.85%
2005 73.481.000 -28.88%
2006 84.071.000 12.6%
2007 81.441.000 -3.23%
2008 89.510.000 9.01%
2009 103.978.000 13.91%
2010 99.093.000 -4.93%
2011 100.003.000 0.91%
2012 102.847.000 2.77%
2013 117.121.000 12.19%
2014 111.166.000 -5.36%
2015 118.828.000 6.45%
2016 128.626.000 7.62%
2017 138.558.000 7.17%
2018 158.050.000 12.33%
2019 146.550.000 -7.85%
2020 147.540.000 0.67%
2021 147.469.000 -0.05%
2022 168.872.000 12.67%
2023 219.494.000 23.06%
2024 201.744.000 -8.8%
2024 203.755.000 0.99%
2025 193.572.000 -5.26%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Kewaunee Scientific Corporation Research and Development Expenses
Year Research and Development Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 872.000 100%
2014 842.000 -3.56%
2015 936.000 10.04%
2016 1.167.000 19.79%
2017 1.163.000 -0.34%
2018 1.537.000 24.33%
2019 1.550.000 0.84%
2020 1.816.000 14.65%
2021 1.406.000 -29.16%
2022 990.000 -42.02%
2023 1.012.000 2.17%
2024 0 0%
2024 920.000 100%
2025 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Kewaunee Scientific Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 0 0%
1994 0 0%
1995 10.900.000 100%
1996 9.800.000 -11.22%
1997 11.500.000 14.78%
1998 13.100.000 12.21%
1999 12.300.000 -6.5%
2000 12.429.000 1.04%
2001 12.156.000 -2.25%
2002 11.801.000 -3.01%
2003 13.476.000 12.43%
2004 13.491.000 0.11%
2005 12.699.000 -6.24%
2006 12.175.000 -4.3%
2007 11.728.000 -3.81%
2008 13.559.000 13.5%
2009 14.289.000 5.11%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 22.939.000 100%
2020 454.000 -4952.64%
2021 1.153.000 60.62%
2022 26.625.000 95.67%
2023 29.706.000 10.37%
2024 160.000 -18466.25%
2024 4.177.000 96.17%
2025 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Kewaunee Scientific Corporation EBITDA
Year EBITDA Growth
1986 -7.200.000
1987 -9.000.000 20%
1988 2.900.000 410.34%
1989 4.000.000 27.5%
1990 1.900.000 -110.53%
1991 1.200.000 -58.33%
1992 1.800.000 33.33%
1993 -1.600.000 212.5%
1994 1.700.000 194.12%
1995 900.000 -88.89%
1996 2.400.000 62.5%
1997 4.000.000 40%
1998 5.600.000 28.57%
1999 6.700.000 16.42%
2000 6.296.000 -6.42%
2001 6.972.000 9.7%
2002 5.084.000 -37.14%
2003 1.515.000 -235.58%
2004 4.060.000 62.68%
2005 1.831.000 -121.74%
2006 2.210.000 17.15%
2007 5.257.000 57.96%
2008 7.547.000 30.34%
2009 9.347.000 19.26%
2010 5.827.000 -60.41%
2011 5.644.000 -3.24%
2012 2.713.000 -108.04%
2013 5.583.000 51.41%
2014 6.359.000 12.2%
2015 5.710.000 -11.37%
2016 6.045.000 5.54%
2017 7.038.000 14.11%
2018 9.779.000 28.03%
2019 2.112.000 -363.02%
2020 -2.373.000 189%
2021 -2.228.000 -6.51%
2022 -1.853.000 -20.24%
2023 6.232.000 129.73%
2024 20.868.000 70.14%
2024 21.406.000 2.51%
2025 14.868.000 -43.97%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Kewaunee Scientific Corporation Gross Profit
Year Gross Profit Growth
1986 13.800.000
1987 10.500.000 -31.43%
1988 21.400.000 50.93%
1989 20.000.000 -7%
1990 17.600.000 -13.64%
1991 17.600.000 0%
1992 16.700.000 -5.39%
1993 12.200.000 -36.89%
1994 14.600.000 16.44%
1995 12.000.000 -21.67%
1996 12.400.000 3.23%
1997 15.500.000 20%
1998 18.700.000 17.11%
1999 19.300.000 3.11%
2000 19.051.000 -1.31%
2001 16.684.000 -14.19%
2002 14.706.000 -13.45%
2003 12.712.000 -15.69%
2004 15.689.000 18.98%
2005 12.484.000 -25.67%
2006 12.408.000 -0.61%
2007 15.086.000 17.75%
2008 19.172.000 21.31%
2009 21.373.000 10.3%
2010 21.403.000 0.14%
2011 19.284.000 -10.99%
2012 19.156.000 -0.67%
2013 22.258.000 13.94%
2014 22.032.000 -1.03%
2015 21.766.000 -1.22%
2016 23.708.000 8.19%
2017 26.607.000 10.9%
2018 32.020.000 16.91%
2019 25.319.000 -26.47%
2020 23.427.000 -8.08%
2021 23.993.000 2.36%
2022 24.220.000 0.94%
2023 35.588.000 31.94%
2024 53.872.000 33.94%
2024 52.971.000 -1.7%
2025 49.952.000 -6.04%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Kewaunee Scientific Corporation Net Profit
Year Net Profit Growth
1986 -800.000
1987 -7.700.000 89.61%
1988 500.000 1640%
1989 1.700.000 70.59%
1990 500.000 -240%
1991 100.000 -400%
1992 800.000 87.5%
1993 -2.500.000 132%
1994 -200.000 -1150%
1995 -1.100.000 81.82%
1996 400.000 375%
1997 2.300.000 82.61%
1998 2.600.000 11.54%
1999 3.400.000 23.53%
2000 3.561.000 4.52%
2001 1.277.000 -178.86%
2002 1.900.000 32.79%
2003 -342.000 655.56%
2004 1.462.000 123.39%
2005 -147.000 1094.56%
2006 193.000 176.17%
2007 1.540.000 87.47%
2008 3.134.000 50.86%
2009 4.247.000 26.21%
2010 3.572.000 -18.9%
2011 1.850.000 -93.08%
2012 1.031.000 -79.44%
2013 3.044.000 66.13%
2014 3.895.000 21.85%
2015 3.529.000 -10.37%
2016 3.802.000 7.18%
2017 4.515.000 15.79%
2018 5.188.000 12.97%
2019 1.529.000 -239.31%
2020 -4.624.000 133.07%
2021 -3.607.000 -28.2%
2022 -6.003.000 39.91%
2023 1.359.000 541.72%
2024 10.928.000 87.56%
2024 18.753.000 41.73%
2025 8.772.000 -113.78%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Kewaunee Scientific Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
1986 0
1987 -3 100%
1988 0 0%
1989 1 0%
1990 0 0%
1991 0 0%
1992 0 0%
1993 -1 100%
1994 0 0%
1995 0 0%
1996 0 0%
1997 1 0%
1998 1 100%
1999 1 0%
2000 1 0%
2001 1 0%
2002 1 0%
2003 0 0%
2004 1 0%
2005 0 0%
2006 0 0%
2007 1 0%
2008 1 100%
2009 2 0%
2010 1 0%
2011 1 0%
2012 0 0%
2013 1 100%
2014 1 0%
2015 1 0%
2016 1 0%
2017 2 0%
2018 2 0%
2019 1 0%
2020 -2 100%
2021 -1 0%
2022 -2 50%
2023 0 0%
2024 4 100%
2024 7 50%
2025 3 -100%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Kewaunee Scientific Corporation Free Cashflow
Year Free Cashflow Growth
1987 0
1989 4.000.000 100%
1990 3.300.000 -21.21%
1991 0 0%
1992 -3.400.000 100%
1993 -300.000 -1033.33%
1994 1.100.000 127.27%
1995 -1.100.000 200%
1996 2.600.000 142.31%
1997 3.000.000 13.33%
1998 1.900.000 -57.89%
1999 -2.400.000 179.17%
2000 -1.157.000 -107.43%
2001 688.000 268.17%
2002 2.394.000 71.26%
2003 -1.844.000 229.83%
2004 -4.398.000 58.07%
2005 2.167.000 302.95%
2006 -2.132.000 201.64%
2007 6.981.000 130.54%
2008 845.000 -726.15%
2009 600.000 -40.83%
2010 294.000 -104.08%
2011 -3.976.000 107.39%
2012 5.488.000 172.45%
2013 1.422.000 -285.94%
2014 6.048.000 76.49%
2015 -277.000 2283.39%
2016 5.084.000 105.45%
2017 9.051.000 43.83%
2018 -212.000 4369.34%
2019 -1.723.000 87.7%
2020 1.696.000 201.59%
2021 -1.485.000 214.21%
2022 -9.793.000 84.84%
2023 -7.938.000 -23.37%
2024 148.000 5463.51%
2024 15.191.000 99.03%
2025 -1.072.000 1517.07%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Kewaunee Scientific Corporation Operating Cashflow
Year Operating Cashflow Growth
1987 0
1989 4.800.000 100%
1990 3.800.000 -26.32%
1991 2.300.000 -65.22%
1992 -1.600.000 243.75%
1993 1.000.000 260%
1994 1.900.000 47.37%
1995 -300.000 733.33%
1996 3.100.000 109.68%
1997 4.200.000 26.19%
1998 3.400.000 -23.53%
1999 1.300.000 -161.54%
2000 2.195.000 40.77%
2001 2.366.000 7.23%
2002 4.459.000 46.94%
2003 1.299.000 -243.26%
2004 -2.779.000 146.74%
2005 3.143.000 188.42%
2006 -246.000 1377.64%
2007 8.705.000 102.83%
2008 3.391.000 -156.71%
2009 2.100.000 -61.48%
2010 4.533.000 53.67%
2011 1.271.000 -256.65%
2012 6.923.000 81.64%
2013 3.827.000 -80.9%
2014 8.069.000 52.57%
2015 2.291.000 -252.2%
2016 7.271.000 68.49%
2017 11.662.000 37.65%
2018 3.183.000 -266.38%
2019 2.490.000 -27.83%
2020 4.161.000 40.16%
2021 912.000 -356.25%
2022 -7.885.000 111.57%
2023 -3.790.000 -108.05%
2024 148.000 2660.81%
2024 19.564.000 99.24%
2025 -794.000 2563.98%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Kewaunee Scientific Corporation Capital Expenditure
Year Capital Expenditure Growth
1987 0
1989 800.000 100%
1990 500.000 -60%
1991 2.300.000 78.26%
1992 1.800.000 -27.78%
1993 1.300.000 -38.46%
1994 800.000 -62.5%
1995 800.000 0%
1996 500.000 -60%
1997 1.200.000 58.33%
1998 1.500.000 20%
1999 3.700.000 59.46%
2000 3.352.000 -10.38%
2001 1.678.000 -99.76%
2002 2.065.000 18.74%
2003 3.143.000 34.3%
2004 1.619.000 -94.13%
2005 976.000 -65.88%
2006 1.886.000 48.25%
2007 1.724.000 -9.4%
2008 2.546.000 32.29%
2009 1.500.000 -69.73%
2010 4.239.000 64.61%
2011 5.247.000 19.21%
2012 1.435.000 -265.64%
2013 2.405.000 40.33%
2014 2.021.000 -19%
2015 2.568.000 21.3%
2016 2.187.000 -17.42%
2017 2.611.000 16.24%
2018 3.395.000 23.09%
2019 4.213.000 19.42%
2020 2.465.000 -70.91%
2021 2.397.000 -2.84%
2022 1.908.000 -25.63%
2023 4.148.000 54%
2024 0 0%
2024 4.373.000 100%
2025 278.000 -1473.02%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Kewaunee Scientific Corporation Equity
Year Equity Growth
1986 25.600.000
1987 17.000.000 -50.59%
1988 17.800.000 4.49%
1989 19.300.000 7.77%
1990 19.400.000 0.52%
1991 19.000.000 -2.11%
1992 18.000.000 -5.56%
1993 15.400.000 -16.88%
1994 15.200.000 -1.32%
1995 14.200.000 -7.04%
1996 14.500.000 2.07%
1997 16.600.000 12.65%
1998 19.000.000 12.63%
1999 22.000.000 13.64%
2000 25.135.000 12.47%
2001 25.761.000 2.43%
2002 26.912.000 4.28%
2003 25.938.000 -3.76%
2004 26.791.000 3.18%
2005 26.589.000 -0.76%
2006 26.364.000 -0.85%
2007 25.230.000 -4.49%
2008 28.715.000 12.14%
2009 28.259.000 -1.61%
2010 31.672.000 10.78%
2011 33.016.000 4.07%
2012 31.658.000 -4.29%
2013 33.693.000 6.04%
2014 34.224.000 1.55%
2015 35.199.000 2.77%
2016 38.552.000 8.7%
2017 44.137.000 12.65%
2018 47.521.000 7.12%
2019 47.703.000 0.38%
2020 38.703.000 -23.25%
2021 41.487.000 6.71%
2022 36.180.000 -14.67%
2023 38.485.000 5.99%
2024 43.414.000 11.35%
2024 56.209.000 22.76%
2025 57.513.000 2.27%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Kewaunee Scientific Corporation Assets
Year Assets Growth
1986 47.300.000
1987 42.200.000 -12.09%
1988 37.300.000 -13.14%
1989 38.900.000 4.11%
1990 38.200.000 -1.83%
1991 37.600.000 -1.6%
1992 36.100.000 -4.16%
1993 31.800.000 -13.52%
1994 31.600.000 -0.63%
1995 30.000.000 -5.33%
1996 26.500.000 -13.21%
1997 27.000.000 1.85%
1998 31.900.000 15.36%
1999 36.000.000 11.39%
2000 39.316.000 8.43%
2001 40.869.000 3.8%
2002 42.190.000 3.13%
2003 43.654.000 3.35%
2004 50.461.000 13.49%
2005 46.212.000 -9.19%
2006 50.472.000 8.44%
2007 45.240.000 -11.56%
2008 50.606.000 10.6%
2009 52.529.000 3.66%
2010 56.621.000 7.23%
2011 63.058.000 10.21%
2012 64.136.000 1.68%
2013 68.742.000 6.7%
2014 62.717.000 -9.61%
2015 69.490.000 9.75%
2016 72.405.000 4.03%
2017 80.397.000 9.94%
2018 84.358.000 4.7%
2019 87.223.000 3.28%
2020 83.929.000 -3.92%
2021 89.384.000 6.1%
2022 118.773.000 24.74%
2023 118.898.000 0.11%
2024 121.708.000 2.31%
2024 134.766.000 9.69%
2025 132.018.000 -2.08%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Kewaunee Scientific Corporation Liabilities
Year Liabilities Growth
1986 21.700.000
1987 25.200.000 13.89%
1988 19.500.000 -29.23%
1989 19.600.000 0.51%
1990 18.800.000 -4.26%
1991 18.600.000 -1.08%
1992 18.100.000 -2.76%
1993 16.400.000 -10.37%
1994 16.400.000 0%
1995 15.800.000 -3.8%
1996 12.000.000 -31.67%
1997 10.400.000 -15.38%
1998 12.900.000 19.38%
1999 14.000.000 7.86%
2000 14.181.000 1.28%
2001 15.108.000 6.14%
2002 15.278.000 1.11%
2003 17.716.000 13.76%
2004 23.670.000 25.15%
2005 19.623.000 -20.62%
2006 24.108.000 18.6%
2007 20.010.000 -20.48%
2008 21.891.000 8.59%
2009 24.270.000 9.8%
2010 24.949.000 2.72%
2011 30.042.000 16.95%
2012 32.478.000 7.5%
2013 35.049.000 7.34%
2014 28.493.000 -23.01%
2015 34.291.000 16.91%
2016 33.853.000 -1.29%
2017 36.260.000 6.64%
2018 36.837.000 1.57%
2019 39.520.000 6.79%
2020 45.226.000 12.62%
2021 47.897.000 5.58%
2022 82.593.000 42.01%
2023 80.413.000 -2.71%
2024 78.294.000 -2.71%
2024 78.557.000 0.33%
2025 74.505.000 -5.44%

Kewaunee Scientific Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
71.01
Net Income per Share
6.48
Price to Earning Ratio
5.03x
Price To Sales Ratio
0.46x
POCF Ratio
8.76
PFCF Ratio
12.31
Price to Book Ratio
1.66
EV to Sales
0.4
EV Over EBITDA
4.04
EV to Operating CashFlow
7.59
EV to FreeCashFlow
10.59
Earnings Yield
0.2
FreeCashFlow Yield
0.08
Market Cap
0,09 Bil.
Enterprise Value
0,08 Bil.
Graham Number
53.56
Graham NetNet
-2.81

Income Statement Metrics

Net Income per Share
6.48
Income Quality
0.57
ROE
0.38
Return On Assets
0.14
Return On Capital Employed
0.17
Net Income per EBT
1.67
EBT Per Ebit
0.69
Ebit per Revenue
0.08
Effective Tax Rate
-0.69

Margins

Sales, General, & Administrative to Revenue
0.02
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.01
Gross Profit Margin
0.27
Operating Profit Margin
0.08
Pretax Profit Margin
0.06
Net Profit Margin
0.09

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
3.72
Free CashFlow per Share
2.67
Capex to Operating CashFlow
0.28
Capex to Revenue
0.01
Capex to Depreciation
0.93
Return on Invested Capital
0.39
Return on Tangible Assets
0.14
Days Sales Outstanding
78.56
Days Payables Outstanding
50.28
Days of Inventory on Hand
47.03
Receivables Turnover
4.65
Payables Turnover
7.26
Inventory Turnover
7.76
Capex per Share
1.05

Balance Sheet

Cash per Share
8,50
Book Value per Share
20,19
Tangible Book Value per Share
20.19
Shareholders Equity per Share
19.66
Interest Debt per Share
4.54
Debt to Equity
0.2
Debt to Assets
0.08
Net Debt to EBITDA
-0.66
Current Ratio
2.53
Tangible Asset Value
0,06 Bil.
Net Current Asset Value
0,02 Bil.
Invested Capital
80068000
Working Capital
0,06 Bil.
Intangibles to Total Assets
0
Average Receivables
0,04 Bil.
Average Payables
0,02 Bil.
Average Inventory
19982000
Debt to Market Cap
0.12

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Kewaunee Scientific Corporation Dividends
Year Dividends Growth
1986 0
1987 0 0%
1988 0 0%
1989 0 0%
1990 0 0%
1991 0 0%
1992 0 0%
1996 0 0%
1997 0 0%
1998 0 0%
1999 0 0%
2000 0 0%
2001 0 0%
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 1 0%
2016 1 0%
2017 1 0%
2018 1 0%
2019 1 0%

Kewaunee Scientific Corporation Profile

About Kewaunee Scientific Corporation

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. It operates through two segments, Domestic and International. The company's products include steel, wood, laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services. Its laboratory products are used in chemistry, physics, biology, and other general science laboratories in the pharmaceutical, biotechnology, industrial, chemical, commercial, educational, government, and health care markets; technical products are used in facilities manufacturing computers and light electronics and by users of computer and networking furniture; and laminate caseworks that are used in educational, healthcare, and industrial applications. The company sells its products primarily through dealers, its subidiaries, and a national distributor. Kewaunee Scientific Corporation was founded in 1906 and is headquartered in Statesville, North Carolina.

CEO
Mr. Thomas D. Hull III
Employee
1.006
Address
2700 West Front Street
Statesville, 28677-2927

Kewaunee Scientific Corporation Executives & BODs

Kewaunee Scientific Corporation Executives & BODs
# Name Age
1 Mr. Bhoopathy Sathyamurthy
Managing Director of International Operations
70
2 Mr. Donald T. Gardner III
Vice President of Finance, Chief Financial Officer, Treasurer & Secretary
70
3 Ms. Elizabeth D. Phillips
Vice President of Human Resources
70
4 Mr. Thomas D. Hull III
President, Chief Executive Officer & Director
70
5 Mr. Douglas J. Batdorff
Vice President of Manufacturing Operations
70
6 Mr. Ryan S. Noble
Vice President of Sales & Marketing - Americas
70

Kewaunee Scientific Corporation Competitors